Gerresheimer (OTCMKTS:GRRMF) Stock Jumps 16.7% – What’s Next?

Gerresheimer AG (OTCMKTS:GRRMF) was up 16.7% on Friday. The company traded as high as $33.90 and last traded at $33.90. 2,000 shares were traded during mid-day trading, an increase of 541% from the average session volume of 312 shares. The stock had previously closed at $29.05.

Analyst Ratings Changes

GRRMF has been the subject of a number of recent analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of Gerresheimer in a research report on Tuesday, August 4th. UBS Group upgraded Gerresheimer from a “sell” rating to a “neutral” rating in a research report on Tuesday, August 4th. Finally, Sanford C. Bernstein upgraded shares of Gerresheimer from an “underperform” rating to a “market perform” rating in a research report on Wednesday, July 1st. Four research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce”.

Gerresheimer Trading Up 16.7%

The stock has a fifty day moving average of $30.79 and a 200-day moving average of $29.48.

About Gerresheimer

Gerresheimer AG is a Germany-based manufacturer of packaging and drug-delivery systems for the pharmaceutical, biotechnology and cosmetics industries. The company develops and produces glass and plastic packaging, including vials, ampoules, syringes, cartridges, bottles and other containers used to store and administer medicines and other sensitive products.

Its portfolio also includes medical devices and drug-delivery solutions such as prefillable syringes, inhalers, pens and other injection-related systems.